BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37674497)

  • 21. Inflammatory Bowel Disease Nurses' Perspectives: Prioritizing Adolescent Transition Readiness Factors.
    Rohatinsky N; Risling T; Hellsten LM; Kumaran M
    J Pediatr Nurs; 2020; 55():29-39. PubMed ID: 32634732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives of health care use and access to care for individuals living with inflammatory bowel disease in rural Canada.
    Rohatinsky N; Boyd I; Dickson A; Fowler S; Peña-Sánchez JN; Quintin CL; Risling T; Russell B; Wicks K; Wicks M
    Rural Remote Health; 2021 Apr; 21(2):6358. PubMed ID: 33820422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in diagnosis of IBD in children.
    Büller HA
    Neth J Med; 1997 Feb; 50(2):S8-11. PubMed ID: 9050326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative Study.
    Dhaliwal J; Carroll MW; deBruyn JC; Ricciuto A; Benchimol EI; Lawrence S; Sherlock M; El-Matary W; Brill H; Church P; Wine E; Carman N; Muise A; Huynh H; Mack DR; Walters TD; Griffiths AM; Jacobson K
    J Crohns Colitis; 2022 Feb; 16(2):216-223. PubMed ID: 34379117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Crowley E; Warner N; Pan J; Khalouei S; Elkadri A; Fiedler K; Foong J; Turinsky AL; Bronte-Tinkew D; Zhang S; Hu J; Tian D; Li D; Horowitz J; Siddiqui I; Upton J; Roifman CM; Church PC; Wall DA; Ramani AK; Kotlarz D; Klein C; Uhlig H; Snapper SB; Gonzaga-Jauregui C; Paterson AD; McGovern DPB; Brudno M; Walters TD; Griffiths AM; Muise AM
    Gastroenterology; 2020 Jun; 158(8):2208-2220. PubMed ID: 32084423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type.
    Griffiths AM; Nicholas D; Smith C; Munk M; Stephens D; Durno C; Sherman PM
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):S46-52. PubMed ID: 10204526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
    Atia O; Shavit-Brunschwig Z; Mould DR; Stein R; Matar M; Aloi M; Ledder O; Focht G; Urlep D; Hyams J; Broide E; Weiss B; Levine J; Russell RK; Turner D
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):31-42. PubMed ID: 36306803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults.
    Osei JA; Peña-Sánchez JN; Fowler SA; Muhajarine N; Kaplan GG; Lix LM
    J Can Assoc Gastroenterol; 2021 Aug; 4(4):186-193. PubMed ID: 34337319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. Foundation.
    El-Matary W; Benchimol EI; Mack D; Huynh HQ; Critch J; Otley A; Deslandres C; Jacobson K; deBruyn J; Carroll MW; Wine E; Van Limbergen J; Sherlock M; Bax K; Lawrence S; Seidman E; Issenman R; Walters TD; Church P; Griffiths AM
    Can J Gastroenterol Hepatol; 2017; 2017():3676474. PubMed ID: 28593172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study.
    Kuenzig ME; Bitton A; Carroll MW; Kaplan GG; Otley AR; Singh H; Nguyen GC; Griffiths AM; Stukel TA; Targownik LE; Jones JL; Murthy SK; McCurdy JD; Bernstein CN; Lix LM; Peña-Sánchez JN; Mack DR; Jacobson K; El-Matary W; Dummer TJB; Fung SG; Spruin S; Nugent Z; Tanyingoh D; Cui Y; Filliter C; Coward S; Siddiq S; Benchimol EI
    J Crohns Colitis; 2021 Dec; 15(12):2031-2040. PubMed ID: 34175936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory Bowel Disorders in Children and Adolescents: Management of Care for Students at School.
    Schaumleffel C
    NASN Sch Nurse; 2023 Sep; 38(5):230-235. PubMed ID: 37222457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalising medicine in inflammatory bowel disease-current and future perspectives.
    Ashton JJ; Mossotto E; Ennis S; Beattie RM
    Transl Pediatr; 2019 Jan; 8(1):56-69. PubMed ID: 30881899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary.
    Windsor JW; Kuenzig ME; Murthy SK; Bitton A; Bernstein CN; Jones JL; Lee K; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Davis T; Weinstein J; Goddard Q; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S1-S8. PubMed ID: 37674500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation of inflammatory bowel disease in Saudi children (Single centre experience).
    Alreheili K; Almehaidib A; Banemi M; Aldekhail W; Alsaleem K
    Int J Pediatr Adolesc Med; 2016 Dec; 3(4):175-179. PubMed ID: 30805489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH REDUCTION IN SCHOOL AND WORK PRODUCTIVITY RATHER THAN PHYSICAL IMPAIRMENT: A MULTIDISCIPLINARY STUDY.
    Oba J; Sobrado CW; Damião AOMC; Azevedo M; Carlos A; Queiroz N; Len CA; Toma RK; Deboni M; Ozaki MJ; Carrilho FJ; Nahas S; Silva CA
    Arq Gastroenterol; 2021; 58(4):541-547. PubMed ID: 34909863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutics for Inflammatory Bowel Diseases in Children and Adolescents: A Focus on Biologics and an Individualized Treatment Paradigm.
    Batra S; Conklin LS
    Handb Exp Pharmacol; 2020; 261():363-375. PubMed ID: 31342277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MICI-MINOTS: Linguistic and metric validation of a pediatric questionnaire on knowledge about inflammatory bowel disease.
    Cousin C; Bevilacqua C; Roman C; Roquelaure B; Loundou A; Baumstarck K; Fabre A
    Arch Pediatr; 2020 Feb; 27(2):110-116. PubMed ID: 31796231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.